Cargando...
Assessing cost-utility of predictive biomarkers in oncology: a streamlined approach
Evaluation of cost-utility is critical in assessing the medical utility of predictive or prognostic biomarkers. Current methods involve complex state-transition models, requiring comprehensive data inputs. We propose a simplified decision-analytic tool to explore the relative effect of factors contr...
Gardado en:
| Publicado en: | Breast Cancer Res Treat |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
2016
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5990969/ https://ncbi.nlm.nih.gov/pubmed/26749360 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-016-3677-3 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|